NCT01043458View on ClinicalTrials.gov

Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2010

Conditions
Schizophrenia
Interventions
DRUG

ABT-126

ABT-126 Low Dose \& ABT-126 High Dose

DRUG

Placebo for ABT-126

Matching Placebo for Arms 1 \& 2

Trial Locations (2)

78217

Site Reference ID/Investigator# 24322, San Antonio

91206

Site Reference ID/Investigator# 25423, Glendale

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY